S
Cassava Sciences D
D
SAVA
2.34000
USD
-0.07
(-2.70%)
مغلق
حجم التداول
28,544
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
113,040,477
الأخبار المقالات
العنوان: Cassava Sciences
القطاع: Healthcare
الصناعة: Biotechnology
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.